Sign in
ZETA-1 Phase 2 Trial Safety and Tolerability Results for APX3330 a New Oral Ref-1 Inhibitor for the Treatment of Diabetic Retinopathy
Daniel Su, MD
Annual Meeting Talks
2023
Episode 191: Dr. Maria Berrocal on EnVision Summit and Diabetic Vitrectomy Revisited
Jayanth Sridhar, MD
Member Podcasts
Small subILM Hemorrhage
Navneet Mehrotra, DNB
Retina Image Bank: Images of the Week
2019
Category: Inflammatory and Infectious Diseases- Exogenous Endophthalmitis